Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04871581
Other study ID # NTI v Placebo
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date June 30, 2020

Study information

Verified date April 2021
Source ChairsideSplint.com
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Single blinding study comparing FDA cleared device for prevention of medically diagnosed migraine pain to placebo.


Description:

In order to determine if nocturnal jaw clenching can be an influence on chronic migraine pain, the FDA cleared "NTI" (Nociceptive Trigeminal Inhibition) device with the Indications for Use of "for prophylactic treatment of medically diagnosed migraine pain" was compared to a similar device that had no influence on jaw clenching.The HIT-6 (Headache Impact Test) score was selected as the outcome measure, as the goal was to focus on improving disability in sufferer's lives, as in chronic migraine, changes in headache days may not be as helpful as improving disability.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date June 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Diagnosed with chronic migraine at a neurology clinic - Exclusion Criteria: none -

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NTI-tss
FDA cleared device for prophylactic treatment of medically diagnosed migraine pain
Placebo
Similar to Device, but having no influence on clenching intensity

Locations

Country Name City State
United States Boyd James Solana Beach California

Sponsors (1)

Lead Sponsor Collaborator
ChairsideSplint.com

Country where clinical trial is conducted

United States, 

References & Publications (14)

Burnett CA, Fartash L, Murray B, Lamey PJ. Masseter and temporalis muscle EMG levels and bite force in migraineurs. Headache. 2000 Nov-Dec;40(10):813-7. — View Citation

Castillo J, Muñoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999 Mar;39(3):190-6. — View Citation

Chandu A, Suvinen TI, Reade PC, Borromeo GL. The effect of an interocclusal appliance on bite force and masseter electromyography in asymptomatic subjects and patients with temporomandibular pain and dysfunction. J Oral Rehabil. 2004 Jun;31(6):530-7. — View Citation

Clark GT, Sakai S, Merrill R, Flack VF, McArthur D, McCreary C. Waking and sleeping temporalis EMG levels in tension-type headache patients. J Orofac Pain. 1997 Fall;11(4):298-306. — View Citation

Goadsby PJ. Migraine pathophysiology. Headache. 2005 Apr;45 Suppl 1:S14-24. Review. — View Citation

Graff-Radford SB, Newman AC. The role of temporomandibular disorders and cervical dysfunction in tension-type headache. Curr Pain Headache Rep. 2002 Oct;6(5):387-91. Review. — View Citation

Graff-Radford SB. Oromandibular disorders and headache. A critical appraisal. Neurol Clin. 1990 Nov;8(4):929-45. Review. — View Citation

Lamey PJ, Barclay SC. Clinical effectiveness of occlusal splint therapy in patients with classical migraine. Scott Med J. 1987 Feb;32(1):11-2. — View Citation

Nishigawa K, Bando E, Nakano M. Quantitative study of bite force during sleep associated bruxism. J Oral Rehabil. 2001 May;28(5):485-91. — View Citation

Pascual J, Colás R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001 Dec;5(6):529-36. Review. — View Citation

Rozen TD. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective). Headache. 2006 May;46(5):750-3. — View Citation

Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000 Jun;13(3):277-83. Review. — View Citation

Steele JG, Lamey PJ, Sharkey SW, Smith GM. Occlusal abnormalities, pericranial muscle and joint tenderness and tooth wear in a group of migraine patients. J Oral Rehabil. 1991 Sep;18(5):453-8. — View Citation

Yap AU, Chua AP. Sleep bruxism: Current knowledge and contemporary management. J Conserv Dent. 2016 Sep-Oct;19(5):383-9. doi: 10.4103/0972-0707.190007. Review. — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement of negative impact on life At least a one-category improvement in subject's HIT-6 score one month
See also
  Status Clinical Trial Phase
Terminated NCT04520425 - Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches N/A
Recruiting NCT06247592 - Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients N/A
Recruiting NCT06133491 - Open Label, 6-month Study for High Frequency and Chronic Migraine,
Recruiting NCT04989413 - Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine - Phase 4
Recruiting NCT06138171 - Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Active, not recruiting NCT06109389 - The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache Phase 2
Withdrawn NCT01749423 - A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines N/A
Terminated NCT04349176 - Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units? Phase 3
Completed NCT05381129 - The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine N/A
Withdrawn NCT03465826 - Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: AIM 4 N/A
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Completed NCT03767062 - Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches N/A
Completed NCT05748535 - Effect of Auricular Vagus Nerve Stimulation in Women With Migraine Disease N/A
Recruiting NCT05724771 - COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study Phase 4
Recruiting NCT05313503 - KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs N/A
Recruiting NCT05079659 - Rate , Predictors and Outcome of Chronic Migraine
Completed NCT03698409 - Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. Phase 4
Completed NCT06118190 - Mesotherapy in the Treatment of Chronic Migraine N/A
Completed NCT04017741 - A Study Investigating the Efficacy of GON Blocks. Phase 4
Completed NCT05679908 - A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine Phase 2